provide evidence that mouse fibroblast cells lacking functional Rb and its related proteins p107 and p130 are more prone to chromosome breakage. On cell division, broken chromosomes are haphazardly distributed between the two daughter cells, which can lead to cells that are missing genetic information on some chromosomes or that carry duplicate copies of some chromosome regions (Fig. 1) .
Apart from implicating Rb in the control of mitotic chromosomes, the three studies have another theme in common: loss of Rb function does not doom cells to death. Consequently, when the function of this protein is compromised, low-level defects in any of these mitotic processes can ensue, setting the stage for inheritance of altered genetic instructions at each cycle of cell division, and incrementally increasing the likelihood of generating a renegade cell with uncontrollable proliferative potential.
How exactly does Rb facilitate chromosome condensation, ensure centromere function and protect chromosomes from breakage? Of particular interest is the molecular machinery that works on chromosomes to condense them. What precise role does condensation have on centromere function? Although general chromosome condensation is abnormal in Rb-deficient cells, chromosomes nevertheless achieve sufficient
CELL CYCLE

Retinoblastoma, a trip organizer
Giovanni Bosco
The retinoblastoma protein is essential for accurate DNA replication, and its loss is commonly associated with cancer. It emerges that this protein also regulates another stage of the cell cycle.
Just as a team of explorers needs a detailed map to guide them on their journey, a cell uses information held within its DNA, and packaged into chromosomes, for guidance throughout its life. It is therefore crucial that genetic information is faithfully maintained for the lifetime of the cell and of its progeny. The tumour-suppressor protein retinoblastoma is known for its role in regulating DNA replication and so maintaining genome stability 1, 2 . Three papers 3-5 published in Genes & Development now also implicate this protein in mediating proper distribution of genetic information between the two daughter cells during mitotic cell division.
Once a cell divides, its genetic information instructs it what shape to assume, what functions to perform, how quickly to proliferate again or whether to stop dividing altogether. Indeed, some of the genes that regulate the cell-division cycle serve as brakes to halt the cell's journey, allowing it to differentiate and settle into its final tissue destination. Incorrect copying of the genetic instructions or damage to the DNA harbouring these instructions could lead the cell to the wrong destination or, worse, to an endless journey -a crisis that warrants cell death. Tumour-suppressor proteins stop cell division under such circumstances. For instance, the retinoblastoma (Rb) protein -the loss of which can cause human eye tumours, as well as most other types of cancer 1 -can stop cell proliferation by limiting the expression of genes that promote DNA replication during the S phase of the cell cycle 1,2 ( Fig. 1) . It thus puts a strong brake on cell division that is removed only when the cell has little chance to pass on erroneous or incomplete genetic instructions.
Just as essential as faithful DNA replication is the accurate distribution of the replicated chromosomes between the two daughter cells during cell division. (By analogy, if members of the explorers' team decide to go their separate ways, accurate copies of the map would be of little use if they were not equally distributed among the explorers.)
Chromosomes are equally segregated into the daughter cells during mitosis, or the M phase of the cell cycle ( Fig. 1 ). There have been hints 2 that Rb also plays a direct part in segregating chromosomes during mitosis, although it remained unclear whether mitotic defects associated with loss of this protein were an indirect consequence of errors committed during the preceding S phase. Could it be that Rb mediates both accurate and timely DNA replication and proper distribution of chromosomes in mitosis? The answer is yes, according to the three new studies [3] [4] [5] . For chromosomes to physically move through the viscous environment of the cell, they must condense into relatively small and stiff shapes. Just like folding a map into a compact form allows its easy storage and protects it against damage during travel, presumably compaction and progress through many cell divisions. To treat cancer, might it be possible to target the chromosome-condensation machinery to completely stall mitosis and so stop tumour-cell division? The new findings [3] [4] [5] give us reason to explore this possibility. 
NEURODEGENERATION
An expansion in ALS genetics
Clotilde Lagier-Tourenne and Don W. Cleveland
Aggregates and mutations of the proteins ataxin-2 and TDP-43 have been implicated in distinct neurodegenerative disorders. An interplay between these proteins is now reported for amyotrophic lateral sclerosis.
Amyotrophic lateral sclerosis (ALS) is a fatal, adult-onset motor-neuron disease. Although the cause of this neuromuscular disorder is not well understood, genetic factors have been implicated in roughly 10% of cases. Elden et al.
1 present evidence on page 1069 of this issue that short expansions of glutamine (Q) amino-acid residues -a polyglutamine, or polyQ tract -in the ataxin-2 protein are associated with increased risk of ALS. This unexpected finding comes 15 years after the discovery 2-4 that long polyQ expansions in ataxin-2 cause spinocere bellar ataxia type 2, a neurodegenerative disorder involving abnormalities of gait. The neurotoxic effects of ataxin-2 seem to be RNA dependent and involve another protein, TDP-43.
That TDP-43, an RNA/DNA-binding protein, is central to the development of neurodegeneration is well documented. Normally found in the nucleus, TDP-43 mislocalizes to the cytoplasm of neurons and glial cells to form protein aggregates in most cases of sporadic ALS 5, 6 , and such mislocalization has been found in a growing number of other neurological disorders, for example frontotemporal lobar dementia (FTLD), Alzheimer's disease and parkinsonism (reviewed in ref. 7). In addition, TDP-43 mutations have been reported in cases of sporadic and familial ALS [8] [9] [10] and in patients with FTLD. How TDP-43 forms aggregates and how this then leads to neuronal death have been largely unknown, although for a few patients mutation in another gene (such as that encoding granulin in FTLD) is one component leading to TDP-43 aggregates.
Elden et al. 1 report that the cytoplasmic protein ataxin-2 may also enhance TDP-43-dependent toxicity to drive the death of motor neurons in ALS. The initial evidence for the role of ataxin-2 as a modulator of TDP-43 damage came from a genetic screen in yeast. The authors then powerfully extended this lesson in yeast to the fruitfly, establishing that TDP-43 toxicity is respectively enhanced or alleviated by increased or reduced levels of the fly ataxin-2.
Elden and colleagues further show that, when wild-type and mutant ataxin-2 or TDP-43 are expressed in yeast and in human cells in culture, these proteins interact physically. Intriguingly, treatment with RNase enzymes, which degrade RNA, or expression of a TDP-43 mutant that cannot bind to RNA abolishes this interaction, indicating that the ataxin-2-TDP-43 association is RNA dependent. Notably, the authors could not detect interaction between the native proteins, which suggests that the interaction does not normally occur and may require an initiating stress, including any that may lead to an age-dependent accumulation of either protein.
Does ataxin-2 also modulate TDP-43 toxicity in humans, and does it have a role in neurodegeneration? Apparently, on both counts it does. Ataxin-2 contains a polyQ tract, which can be of variable length -most commonly 22 or 23 residues. An expansion of this tract to 34 or more repeats causes, in most instances, spinocerebellar ataxia type 2 (SCA2) 2-4 and, in some instances, parkinsonism. Elden et al. 1 demonstrate that the length of the ataxin-2 polyQ tract in humans influences TDP-43 toxicity in motor neurons, thereby also contributing to ALS (Fig. 1) .
The authors report that intermediate-length polyQ-tract expansions are a risk factor for ALS. Expansions ranging from 27 to 33 repeats occurred in 4.7% of around 900 patients with ALS, but in only 1.4% of healthy individuals. Association of ataxin-2 intermediate-length polyQ expansions with ALS was also accompanied by a significantly earlier age of disease onset.
A common feature of SCA2 and ALS is the presence of cytoplasmic aggregates of TDP-43 and ataxin-2 in the affected cells. Indeed, Elden et al.
1 find TDP-43 cytoplasmic inclusions in the cere bellum and brainstem of patients with SCA2, adding this disorder to the list of conditions involving abnormalities in TDP-43. The
